-
公开(公告)号:US20120130404A1
公开(公告)日:2012-05-24
申请号:US13361444
申请日:2012-01-30
IPC分类号: A61B17/04
CPC分类号: A61B17/0469 , A61B17/0482 , A61B17/0491 , A61B17/06066 , A61B17/0625 , A61B17/29 , A61B17/34 , A61B34/30 , A61B34/71 , A61B2017/0023 , A61B2017/00398 , A61B2017/00407 , A61B2017/00473 , A61B2017/047 , A61B2017/0474 , A61B2017/06028 , A61B2017/0608 , A61B2017/06085 , A61B2017/2923 , A61B2017/2927 , A61B2017/2943 , A61B2217/007
摘要: An apparatus and method for minimally invasive suturing is disclosed. A suturing device for minimally invasive suturing includes proximal section having a proximal end, a distal end, and a longitudinal axis therebetween; a suture head assembly extending from the distal end of the proximal section; a suturing needle having a pointed end and a blunt end, the suturing needle capable of rotating about an axis approximately perpendicular to a longitudinal axis of the proximal section, wherein the pointed end of the suturing needle is positioned within the suture head assembly prior to and after rotation of the suturing needle; and an actuator extending from the proximal end of the proximal section to actuate a drive mechanism having a needle driver for engaging and rotating the suturing needle.
摘要翻译: 公开了一种用于微创缝合的装置和方法。 用于微创缝合的缝合装置包括具有近端,远端和其间的纵向轴线的近端部分; 缝合头组件,其从近端部分的远端延伸; 具有尖端和钝端的缝合针,所述缝合针能够绕近似垂直于所述近端部分的纵向轴线的轴线旋转,其中所述缝合针的尖端位于所述缝合线头组件之前和 缝合针旋转后; 以及从所述近端部分的近端延伸的致动器,以致动具有用于接合和旋转所述缝合针的针驱动器的驱动机构。
-
公开(公告)号:US08123764B2
公开(公告)日:2012-02-28
申请号:US12592174
申请日:2009-11-20
IPC分类号: A61B17/04
CPC分类号: A61B17/0469 , A61B17/0482 , A61B17/0491 , A61B17/06066 , A61B17/0625 , A61B17/29 , A61B17/34 , A61B34/30 , A61B34/71 , A61B2017/0023 , A61B2017/00398 , A61B2017/00407 , A61B2017/00473 , A61B2017/047 , A61B2017/0474 , A61B2017/06028 , A61B2017/0608 , A61B2017/06085 , A61B2017/2923 , A61B2017/2927 , A61B2017/2943 , A61B2217/007
摘要: An apparatus and method for minimally invasive suturing is disclosed. A suturing device for minimally invasive suturing includes proximal section having a proximal end, a distal end, and a longitudinal axis therebetween; a suture head assembly extending from the distal end of the proximal section; a suturing needle having a pointed end and a blunt end, the suturing needle capable of rotating about an axis approximately perpendicular to a longitudinal axis of the proximal section, wherein the pointed end of the suturing needle is positioned within the suture head assembly prior to and after rotation of the suturing needle; and an actuator extending from the proximal end of the proximal section to actuate a drive mechanism having a needle driver for engaging and rotating the suturing needle.
摘要翻译: 公开了一种用于微创缝合的装置和方法。 用于微创缝合的缝合装置包括具有近端,远端和其间的纵向轴线的近端部分; 缝合头组件,其从近端部分的远端延伸; 具有尖端和钝端的缝合针,所述缝合针能够围绕近似垂直于所述近端部分的纵向轴线的轴线旋转,其中所述缝合针的尖端位于所述缝合线头组件之前和 缝合针旋转后; 以及从所述近端部分的近端延伸的致动器,以致动具有用于接合和旋转所述缝合针的针驱动器的驱动机构。
-
公开(公告)号:US07816522B2
公开(公告)日:2010-10-19
申请号:US11723893
申请日:2007-03-22
申请人: Richard Clark , Fumiyoshi Matsuura , Kazunobu Kira , Shinsuke Hirota , Hiroshi Azuma , Tadashi Nagakura , Tatsuo Horizoe , Kimiyo Tabata , Kazutomi Kusano , Takao Omae , Atsushi Inoue
发明人: Richard Clark , Fumiyoshi Matsuura , Kazunobu Kira , Shinsuke Hirota , Hiroshi Azuma , Tadashi Nagakura , Tatsuo Horizoe , Kimiyo Tabata , Kazutomi Kusano , Takao Omae , Atsushi Inoue
IPC分类号: A61K31/41 , A61K31/415 , C07D233/00 , C07D249/00
CPC分类号: C07D249/12 , C07D401/04 , C07D401/06 , C07D401/14 , C07D403/04 , C07D403/14 , C07D405/06 , C07D405/14 , C07D409/04 , C07D413/14 , C07D417/04
摘要: A Compound represented by the following general formula (1), salts thereof or hydrates of the foregoing is a novel compound useful for treatment and/or prevention of diseases associated with thrombus formation, and which is safer with suitable physicochemical stability. [wherein R1a, R1b, R1c and R1d each independently represent hydrogen, etc.; R2 represents optionally substituted phenyl, etc.; R3 represents optionally substituted C6-10 aryl, etc.; and Z1 and Z2 each independently represent hydrogen]
摘要翻译: 由以下通式(1)表示的化合物,其盐或其前体的水合物是可用于治疗和/或预防与血栓形成有关的疾病的新型化合物,其具有合适的理化稳定性更安全。 [其中R1a,R1b,R1c和R1d各自独立地表示氢等; R2代表任选取代的苯基等; R3代表任选取代的C6-10芳基等; 并且Z 1和Z 2各自独立地表示氢]
-
公开(公告)号:US07807690B2
公开(公告)日:2010-10-05
申请号:US12234116
申请日:2008-09-19
申请人: Richard Clark , Atsushi Takemura , Nobuhisa Watanabe , Osamu Asano , Tadashi Nagakura , Kimiyo Tabata
发明人: Richard Clark , Atsushi Takemura , Nobuhisa Watanabe , Osamu Asano , Tadashi Nagakura , Kimiyo Tabata
IPC分类号: A61K31/506 , A61K31/4439 , A61K31/427 , A61K31/422 , A61K31/4196 , C07D401/14 , C07D403/14 , C07D413/14 , C07D417/14 , C07D249/12
CPC分类号: C07D417/14 , C07D209/44 , C07D401/12 , C07D401/14 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14
摘要: A compound represented by the following general formula (1), or a salt thereof has serine protease inhibiting activity, and particularly excellent inhibiting activity against clotting factor VIIa. This compound or a salt thereof is useful as therapeutic and/or prophylactic agents for diseases associated with thrombus formation. [wherein R1 represents hydrogen, R2 represents optionally substituted phenyl, etc., R3 represents optionally substituted C6-10 aryl, etc.].
摘要翻译: 由以下通式(1)表示的化合物或其盐具有丝氨酸蛋白酶抑制活性,对凝血因子VIIa特别优异的抑制活性。 该化合物或其盐可用作与血栓形成相关的疾病的治疗和/或预防剂。 [其中R1表示氢,R2表示任选取代的苯基等,R 3表示任选取代的C 6-10芳基等]。
-
公开(公告)号:US07772226B2
公开(公告)日:2010-08-10
申请号:US12199982
申请日:2008-08-28
申请人: Seiji Yoshikawa , Eita Emori , Fumiyoshi Matsuura , Richard Clark , Hironori Ikuta , Kazunobu Kira , Nobuyuki Yasuda , Tadashi Nagakura , Kazuto Yamazaki
发明人: Seiji Yoshikawa , Eita Emori , Fumiyoshi Matsuura , Richard Clark , Hironori Ikuta , Kazunobu Kira , Nobuyuki Yasuda , Tadashi Nagakura , Kazuto Yamazaki
IPC分类号: A61K31/437 , A61K31/496 , C07D487/04 , C07D471/04 , C07D473/06 , C07D473/18 , C07D473/22 , C07D473/30 , C07D473/40 , C07D498/14 , A61K31/5025 , A61K31/522
CPC分类号: C07D473/30 , C07D471/04 , C07D473/04 , C07D473/06 , C07D473/18 , C07D473/36 , C07D473/40 , C07D487/04 , C07D491/14
摘要: The present invention is related to compounds represented by the following formula, or salts or hydrates thereof wherein, T1 represents a 4- to 12-membered heterocyclic group containing one or two nitrogen atoms in the ring, which is a monocyclic or bicyclic structure that may have one or more substituents; X represents a C1-6 alkyl group which may have one or more substituents, or such; Z1 and Z2 each independently represent a nitrogen atom or a group represented by the formula —CR2—; R1 and R2 independently represent a hydrogen atom, a C1-6 alkyl group which may have one or more substituents, or a C1-6 alkoxy group which may have one or more substituents, or such. These are novel compounds that exhibit an excellent DPPIV-inhibiting activity.
摘要翻译: 本发明涉及由下式表示的化合物或其盐或水合物,其中,T1表示在环中含有一个或两个氮原子的4至12元杂环基,其为单环或双环结构,其可以是 具有一个或多个取代基; X表示可以具有一个或多个取代基的C 1-6烷基; Z 1和Z 2各自独立地表示氮原子或由式-CR 2表示的基团; R1和R2独立地表示氢原子,可以具有一个或多个取代基的C 1-6烷基或可以具有一个或多个取代基的C 1-6烷氧基等。 这些是表现出优异的DPPIV抑制活性的新型化合物。
-
公开(公告)号:US20100120670A1
公开(公告)日:2010-05-13
申请号:US12297110
申请日:2007-04-03
申请人: Richard Clark , David James Craik
发明人: Richard Clark , David James Craik
摘要: This invention relates to an oral or enteral pharmaceutical preparation comprising at least one synthetically cyclised alpha-conotoxin peptide having an amide cyclised backbone such that the peptide has no free N- or C-terminus, said peptide having the ability to inhibit a nicotinic acetylcholine receptor and comprising four cysteine residues bonded in pairs to form two disulfide bonds, wherein the N-terminus of the corresponding linear/non-cyclised conotoxin peptide is linked to the C-terminus by a peptide linker, in a vehicle which is pharmaceutically suitable for oral or enteral administration.
摘要翻译: 本发明涉及口服或肠内药物制剂,其包含至少一种具有酰胺环化主链的合成环化的α-芋螺毒素肽,使得肽不具有游离的N-或C-末端,所述肽具有抑制烟碱乙酰胆碱受体的能力 并且包含成对结合以形成两个二硫键的四个半胱氨酸残基,其中相应的线性/非环化的芋螺毒素肽的N-末端通过肽接头在C末端连接,其药学上适用于口服 或肠内管理。
-
公开(公告)号:US07693784B2
公开(公告)日:2010-04-06
申请号:US11514206
申请日:2006-09-01
申请人: Serge Rivest , Michael King , Richard Clark
发明人: Serge Rivest , Michael King , Richard Clark
IPC分类号: G06Q40/00
CPC分类号: G06Q40/06 , G06Q20/10 , G06Q20/102 , G06Q30/08 , G06Q40/00 , G06Q40/02 , G06Q40/025
摘要: A system and method of providing a client with cashflow monitoring during a transfer of services (e.g. pre-authorized debits and credits) from a first account to a second account, the method comprising the steps of: (i) determining an effective date for the transfer of each service, said effective dates creating a transfer window; (ii) determining cashflows for said first account and said second account during said transfer window; (iii) adjusting effective dates for transfer of each services to avoid cashflow interruptions in said first and said second accounts; and (iv) providing a cashflow analysis to the client that lists all the effective dates for each service transfer and predicted cashflows for said first and said second account during said transfer window.
摘要翻译: 一种在从第一帐户转移到第二帐户的服务转移(例如预授权借记和信用)期间向客户提供现金流监视的系统和方法,所述方法包括以下步骤:(i)确定所述客户端的生效日期 传输每个服务,表示生效日期创建一个转移窗口; (ii)在所述传送窗口期间确定所述第一帐户和所述第二帐户的现金流; (iii)调整每个服务的转移的生效日期以避免所述第一和第二帐户中的现金流中断; 以及(iv)向所述客户提供现金流分析,列出在所述转移窗口期间所述第一帐户和所述第二账户的每个服务转移的所有生效日期和所述预测的现金流。
-
公开(公告)号:US07544835B2
公开(公告)日:2009-06-09
申请号:US10472543
申请日:2002-04-18
申请人: Fumiyoshi Matsuura , Eita Emori , Masanobu Shinoda , Richard Clark , Shunji Kasai , Hideki Yoshitomi , Kazuto Yamazaki , Takashi Inoue , Sadakazu Miyashita , Taro Hihara , Hitoshi Harada , Kaya Ohashi
发明人: Fumiyoshi Matsuura , Eita Emori , Masanobu Shinoda , Richard Clark , Shunji Kasai , Hideki Yoshitomi , Kazuto Yamazaki , Takashi Inoue , Sadakazu Miyashita , Taro Hihara , Hitoshi Harada , Kaya Ohashi
CPC分类号: C07D413/12 , C07C59/58 , C07C59/68 , C07C59/72 , C07C233/25 , C07C235/24 , C07C251/48 , C07C251/52 , C07C251/54 , C07C255/37 , C07C255/54 , C07C259/10 , C07C271/14 , C07C271/16 , C07C271/22 , C07C271/28 , C07C271/58 , C07C309/73 , C07C309/75 , C07C311/19 , C07C317/18 , C07C317/22 , C07C323/20 , C07D209/08 , C07D209/18 , C07D209/24 , C07D213/30 , C07D213/65 , C07D213/68 , C07D213/73 , C07D213/75 , C07D215/14 , C07D215/18 , C07D215/26 , C07D235/06 , C07D235/12 , C07D277/56 , C07D295/096 , C07D295/192 , C07D307/79 , C07D317/54 , C07D417/12
摘要: Carboxylic acid compound or salt or hydrate thereof useful as insulin sensitizer, represented by the formula wherein R1 represents hydrogen, hydroxyl, halogen, carboxyl, or C1-6 alkyl, L represents single bond or C1-6-alkylene, C2-6-alkenylene, or C2-6-alkynylene, M represents single bond or C1-6-alkylene, C2-6-alkenylene, or C2-6-alkynylene, T represents single bond, or C1-3-alkylene, C2-3-alkenylene, or C2-3-alkynylene, W represents carboxyl, represents single bond, X represents single bond, oxygen, —NRX1CQ1O—, —OCQ1NRX1—, —CQ1NRX1O—, ONRX1CQ1—, —Q2SO2—, or —SO2Q2—, Y represents 5- to 14-membered aromatic group, and ring Z represents 5- to 14-membered aromatic group.
摘要翻译: 可用作胰岛素敏化剂的羧酸化合物或其盐或水合物,其由下式表示:其中R 1表示氢,羟基,卤素,羧基或C 1-6烷基,L表示单键或C 1-6 - 亚烷基,C 2-6亚烯基 或C 2-6亚炔基,M表示单键或C 1-6 - 亚烷基,C 2-6亚烯基或C 2-6亚炔基,T表示单键,或C 1-3 - 亚烷基,C 2-3亚烯基, 或C2-3亚炔基,W表示羧基,表示单键,X表示单键,氧,-NRX1CQ10,-OCQ1NRX1,-CQ1NRX10,ONRX1CQ1,-Q2SO2-或-SO2Q2-,Y表示5- 至14元芳族基团,并且环Z表示5至14元芳族基团。
-
公开(公告)号:US07371777B2
公开(公告)日:2008-05-13
申请号:US10486396
申请日:2002-08-16
申请人: Richard Clark , Fumiyoshi Matsuura , Eita Emori , Masanobu Shinoda , Shunji Kasai , Hideki Yoshitomi , Kazuto Yamazaki , Takashi Inoue , Sadakazu Miyashita , Taro Hihara
发明人: Richard Clark , Fumiyoshi Matsuura , Eita Emori , Masanobu Shinoda , Shunji Kasai , Hideki Yoshitomi , Kazuto Yamazaki , Takashi Inoue , Sadakazu Miyashita , Taro Hihara
IPC分类号: A61K31/341 , C07D307/04
CPC分类号: C07D213/53 , C07C233/87 , C07C251/60 , C07C2601/02 , C07C2601/14 , C07D263/32 , C07D277/56 , C07D307/24 , C07D307/30 , C07D317/32 , C07D339/08 , C07D405/06 , C07D405/12 , C07D407/12 , C07D413/12 , C07D417/12 , C07D417/14
摘要: The present invention provides a novel compound having an excellent PPAR agonist action. More specifically, it provides a compound represented by the following formula, a salt thereof, an ester thereof or a hydrate of them. Wherein a, b and c are the same as or different from one another and each represents 0 to 4; R1 to R6 are the same as or different from one another and each represents a hydrogen atom, a hydroxyl group, a cyano group, a halogen atom, etc.; A1 and A2 are the same as or different from each other and each represents a single bond, an oxygen atom, etc.; L, M and T each represent a single bond, an alkylene group having one to six carbon atoms, etc.; W represents a carboxyl group; the partial structure represented by the formula: represents a single bond or a double bond; X represents a single bond, an oxygen atom, —NRx1CQ1O—, etc.; Y represents Y1—Y2— (wherein Y1 represents a 5 to 14-membered aromatic ring having one to four substituents, etc.; and Y2 represents a single bond or a 5 to 14-membered aromatic ring); and the ring Z represents a 5 to 14-membered aromatic ring which have one to four substituents selected form the above-mentioned Group A, may have one or more hetero atoms and may be partially saturated.
摘要翻译: 本发明提供具有优异的PPAR激动剂作用的新化合物。 更具体地,它提供由下式表示的化合物,其盐,其酯或它们的水合物。 其中a,b和c彼此相同或不同,各自表示0〜4; R 1至R 6彼此相同或不同,并且各自表示氢原子,羟基,氰基,卤素原子等; A< 1>和< 2>相同或不同,各自表示单键,氧原子等; L,M和T各自表示单键,具有1〜6个碳原子的亚烷基等; W表示羧基; 由式表示的部分结构表示单键或双键; X表示单键,氧原子,-O- O 1等。 Y表示Y 1 -Y 2 - (其中Y 1表示具有1〜4个取代基的5〜14元芳香环等。 ; Y 2代表单键或5至14元芳环); 并且环Z表示具有一至四个选自上述A组的取代基的5至14元芳环,可具有一个或多个杂原子并且可部分饱和。
-
公开(公告)号:US20080033220A1
公开(公告)日:2008-02-07
申请号:US11768754
申请日:2007-06-26
申请人: Richard Clark , Richard Stradling , Robert Wardle
发明人: Richard Clark , Richard Stradling , Robert Wardle
IPC分类号: C10L10/12
CPC分类号: C10L1/08 , C10L1/14 , C10L1/1616 , C10L1/231 , C10L10/12
摘要: A method for increasing the cetane number of a fuel composition containing a Fischer-Tropsch derived fuel component, in order to reach a target cetane number X, is provided by adding to the composition a concentration c of an ignition improver, wherein c is lower than the concentration which theory would predict needed to be added in order to achieve the target. The ignition improver is preferably 2-ethylhexyl nitrate and the fuel composition suitably a diesel or kerosene fuel. A fuel composition for use in a compression ignition engine, which has a cetane number of 85 or greater, and contains a Fischer-Tropsch derived fuel component and an ignition improver is also disclosed.
摘要翻译: 通过向组合物中加入点燃改进剂的浓度c,提供含有费 - 托衍生燃料成分的燃料组合物的十六烷值以达到目标十六烷值X的方法,其中c低于 为了实现目标,需要加入理论预测的浓度。 点火改进剂优选为硝酸2-乙基己酯,燃料组合物合适地为柴油或煤油燃料。 还公开了一种用于压缩点火式发动机的十六烷值为85以上并且含有费 - 托衍生燃料成分和点燃改进剂的燃料组合物。
-
-
-
-
-
-
-
-
-